INVO INVO Bioscience Inc

Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today's pre-market trading after reporting fourth-quarter results. read more...

NAYA to accelerate Phase II clinical development and Early Patient Access after initial safety demonstrated in 28-patient clinical trialProgram developed by Florida Biotechnologies, Inc. & the...

INVO (NASDAQ: INVO) and NAYA Biosciences expect to close their previously announced merger in the first quarter of 2024Experienced, entrepreneurial leadership team to help structure merged public...